TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03795038 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02777073 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01624701 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00788944 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01397916 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT01212510 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03837353 — Predictive Biomarker (PRD): DKK1 mRNA
Genes: DKK1; UNQ492/PRO1008
Study NCT03566797 — Predictive Biomarker (PRD): NOD2 mRNA
Genes: NOD2; CARD15; IBD1
Study NCT00374855 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00374855 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04380766 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT00730223 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT03199469 — Predictive Biomarker (PRD): MTM1 mRNA
Genes: MTM1; CG2
Study NCT01265433 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT02146963 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02146963 — Safety Biomarker (SAF): BDNF
Study NCT01667835 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03643965 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00721630 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04923789 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT02531750 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02531750 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00201409 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04331574 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03509805 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04439370 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01781767 — Predictive Biomarker (PRD): UCP2 mRNA
Genes: UCP2; SLC25A8
Study NCT02197234 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02197234 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02197234 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01890135 — Predictive Biomarker (PRD): EDNRA mRNA
Genes: EDNRA; ETA; ETRA
Study NCT02100943 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01408472 — Predictive Biomarker (PRD): CNTF mRNA
Genes: CNTF
Study NCT02104999 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03031925 — Predictive Biomarker (PRD): ANXA2 mRNA
Genes: ANXA2; ANX2; ANX2L4; CAL1H; LPC2D
Study NCT03031925 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT02950389 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02950389 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT00843349 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT00089648 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00089648 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01393470 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02501772 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01230112 — Predictive Biomarker (PRD): ITGAM mRNA
Genes: ITGAM; CD11B; CR3A
Study NCT04084626 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03226587 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02295059 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01865461 — Predictive Biomarker (PRD): Liver iron
Study NCT00058981 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT03391895 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02335853 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04705857 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02561299 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT01456455 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00572403 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02590887 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT02590887 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT02590887 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02590887 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05386940 — Predictive Biomarker (PRD): PKN1 mRNA
Genes: PKN1; PAK1; PKN; PRK1; PRKCL1
Study NCT00793975 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02927873 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01766817 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03472235 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00954876 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00954876 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04364269 — Predictive Biomarker (PRD): VIT mRNA
Genes: VIT; UNQ647/PRO1277
Study NCT02186626 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02390128 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT02167854 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00936897 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02648100 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02089035 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02940132 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02940132 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT01802554 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01802554 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04339283 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02875652 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03624686 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04229173 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT00642278 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05074719 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03367208 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03781401 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00698061 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT00177411 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04229823 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study NCT03588117 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03193073 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT03193073 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03786393 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00927394 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00927394 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04400032 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01221363 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04094766 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04094766 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03587324 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study NCT03996629 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT00593905 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04574921 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02216786 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02216786 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00389519 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01987479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01681576 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01555775 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT04277143 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02361788 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT03563651 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00676143 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02832713 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01894594 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00552851 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03253055 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03608865 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04249869 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study NCT03179215 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01385644 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03539861 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03539861 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02290886 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02290886 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT02290886 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT01115738 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04662216 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01363557 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04986384 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT04986384 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04148599 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04304040 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT01635010 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04113863 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04113863 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05405348 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00959257 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04584658 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00141609 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03159637 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02299141 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02299141 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT02299141 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01200641 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04648202 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study NCT02066948 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02201212 — Predictive Biomarker (PRD): MTOR mRNA
Genes: MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1
Study NCT01899391 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study NCT00509795 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03761264 — Surrogate Endpoint (SUR): Bacterial count
Study NCT00042211 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01348243 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04173949 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04173949 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00390247 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00390247 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00390247 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02359695 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study NCT03397355 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01648452 — Predictive Biomarker (PRD): CNTF mRNA
Genes: CNTF
Study NCT01648452 — Predictive Biomarker (PRD): CNGB3 mRNA
Genes: CNGB3
Study NCT02927340 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02927340 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT02927340 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04212858 — Predictive Biomarker (PRD): ZNF217 mRNA
Genes: ZNF217; ZABC1
Study NCT01026987 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01026987 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03452891 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT02855450 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT02309359 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT00977145 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03309592 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00405808 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00836277 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02204306 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01336166 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT03034967 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study NCT03557879 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT03696238 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03864016 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02197910 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02197910 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02598908 — Safety Biomarker (SAF): Thiopurine S-methyltransferase
Genes: TPMT
Study NCT03685669 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01977274 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT01565057 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT00549991 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01649960 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT01283035 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT00182247 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02113553 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01568554 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT03812549 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01023438 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01885195 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT04239820 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT02083718 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01197144 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00778804 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00872794 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01426529 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00316095 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03582748 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03337152 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT02990858 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT04223557 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03210532 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00303459 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02959151 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT04622319 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04568902 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04568902 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04438018 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04438018 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03749083 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02654119 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03193151 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT00044304 — Predictive Biomarker (PRD): FIP1L1 mRNA
Genes: FIP1L1; FIP1; RHE
Study NCT00044304 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT02018965 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03294460 — Predictive Biomarker (PRD): CHRNA5 mRNA
Genes: CHRNA5; NACHRA5
Study NCT03283267 — Surrogate Endpoint (SUR): Serum potassium
Study NCT04307836 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03745716 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00729573 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02216370 — Predictive Biomarker (PRD): PITX2 mRNA
Genes: PITX2; ARP1; RGS; RIEG; RIEG1
Study NCT02796794 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03734939 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01499459 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02784912 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04670094 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03146962 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03146962 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT04047758 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04047758 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00965783 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00592553 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00592553 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT04651413 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00714610 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01934335 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT05372159 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT01613833 — Predictive Biomarker (PRD): A2M mRNA
Genes: A2M; CPAMD5; FWP007
Study NCT04406844 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01191905 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03685721 — Predictive Biomarker (PRD): PKLR mRNA
Genes: PKLR; PK1; PKL
Study NCT02489253 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT00519688 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00749164 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04328961 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04530435 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT02287818 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT01336452 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02516774 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04043026 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01111825 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03229499 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03357653 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01211171 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02831777 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02640209 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03466021 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01544231 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02057341 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1